CHENGDA PHARMA(SZ:301201) Zheng Quan Zhi Xing·2025-07-16 09:21Core Viewpoint - The announcement details the listing and circulation of certain shares prior to the initial public offering (IPO) of Chengda Pharmaceutical Co., Ltd, highlighting the changes in share structure and the commitments made by shareholders regarding share transfer restrictions [1][5][12]. Summary by Sections Initial Public Offering and Share Capital Changes - Chengda Pharmaceutical successfully completed its IPO, issuing 24,174,035 shares, resulting in a total share capital of 72,522,105 shares before the IPO and 96,696,140 shares after [1][2]. - The proportion of shares subject to trading restrictions was 77.23% of the total share capital post-IPO [1]. Changes in Share Structure Post-IPO - Following the lifting of restrictions on certain shares, the total share capital increased to 96,696,140 shares, with 23,266,070 shares being unrestricted, representing 24.06% of the total [2]. - After further share releases, the total share capital reached 154,713,824 shares, with unrestricted shares amounting to 87,193,824, accounting for 56.36% of the total [4][12]. Shareholder Commitments and Lock-up Periods - Key shareholders, including directors and investment partners, committed to not transferring their shares for 36 months post-IPO, with specific conditions for extending lock-up periods if share prices fell below the IPO price [5][6][9]. - The commitments were adhered to, and there were no violations affecting the listing of restricted shares [9][12]. Listing and Circulation of Restricted Shares - The total number of restricted shares being released for circulation was 67,520,000, which constituted 44.58% of the total share capital after excluding repurchased shares [10][12]. - The company confirmed that the released shares were not subject to any pledges or freezes [10]. Regulatory Compliance and Verification - The sponsor institution verified that all shareholder commitments were fulfilled and that the listing of restricted shares complied with relevant laws and regulations [12].